National Differences For Pharmacovigilance Requirements In Europe.
Webinar date & time: March 7th 15:00 CET
Join our webinar on “Navigating National Differences in Setting up a Pharmacovigilance System in Europe.” This session will discuss the regulations and guidelines to consider when implementing a pharmacovigilance system in Europe.
From country-specific reporting requirements to cultural considerations, we will cover the key factors you must consider to ensure compliance and effective pharmacovigilance practices across the region. Whether you’re a pharmaceutical company looking to expand into the European market, or an existing player looking to optimize your pharmacovigilance processes, this webinar will provide valuable insights and practical tips for success.
The webinar will lead by our field experts, who share their experiences and best practices. So let’s dive in and explore the complexities and opportunities of pharmacovigilance in Europe.
Register here!
Albert Befki, MSc
Head of Global Pharmacovigilance Operations
Albert is a pharmacovigilance expert with over 11 years of experience in the field. He has vast experience in different pharmacovigilance operations, from literature monitoring, vendor management, global and local case processing oversight, to safety database management. Before joining Biomapas, Albert held several strategic pharmacovigilance roles in various outsourcing service providers. He has extensive leadership experience in the pharma industry, which led him to become the Head of Pharmacovigilance Operations at Biomapas.
Setting up Pharmacovigilance In Europe?
Let’s talk how we can team up to conduct them effectively and ensure smooth processes.
Other content that might interest you:
When Do Biotech Companies and Startups Need Pharmacovigilance
Many biotech startups assume pharmacovigilance begins after approval, but regulatory expectations and clinical trial complexity often require safety oversight much earlier. Learn when pharmacovigilance becomes essential and how to stay compliant as you scale.
How to Build Clinical Safety for Biotechs Without a Full Department
Discover how biotech companies can build scalable clinical safety management early, ensuring compliance, oversight, and efficient operations across development phases.
Clinical Safety Management in Pharma: How to Manage Risk Across the Drug Development Lifecycle
Learn how effective clinical trial safety management supports risk mitigation, regulatory compliance, and patient safety across all stages of drug development.
